These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity. Passarelli A; Carbone V; Pignata S; Mazzeo R; Lorusso D; Scambia G; Canova S; Di Palma T; Tasca G; Mantiero M; Naglieri E; Andreetta C; Rauso M; Brunetti AE; Laera L; Abeni C; Scandurra G; Gambaro AR; Pastore A; Bengala C; Gunnellini M; Farolfi A; Spinello M; Bartoletti M Gynecol Oncol; 2024 Apr; 183():61-67. PubMed ID: 38518529 [TBL] [Abstract][Full Text] [Related]
4. Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma. Basu M; Chakraborty B; Ghosh S; Samadder S; Dutta S; Roy A; Pal DK; Ghosh A; Panda CK Mutagenesis; 2020 Dec; 35(6):499-508. PubMed ID: 33400797 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. Juric D; Rodon J; Tabernero J; Janku F; Burris HA; Schellens JHM; Middleton MR; Berlin J; Schuler M; Gil-Martin M; Rugo HS; Seggewiss-Bernhardt R; Huang A; Bootle D; Demanse D; Blumenstein L; Coughlin C; Quadt C; Baselga J J Clin Oncol; 2018 May; 36(13):1291-1299. PubMed ID: 29401002 [TBL] [Abstract][Full Text] [Related]
6. PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma. Cao J; Zeng K; Chen Q; Yang T; Lu F; Lin C; Zhan J; Ma W; Zhou T; Huang Y; Luo F; Zhao H Cell Death Dis; 2024 Mar; 15(3):237. PubMed ID: 38555280 [TBL] [Abstract][Full Text] [Related]
7. Role of INPP4B in the proliferation, migration, invasion, and survival of human endometrial cancer cells. Zhao J; Du XM; Si W; Zhao XH; Zhou ZQ Histol Histopathol; 2024 Sep; 39(9):1197-1208. PubMed ID: 38318760 [TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of Smok-Kalwat J; Chmielewski G; Stando R; Sadowski J; Macek P; Kowalik A; Nowak-Ozimek E; Góźdź S Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761256 [TBL] [Abstract][Full Text] [Related]
9. The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study. Kodada D; Hyblova M; Krumpolec P; Janostiakova N; Barath P; Grendar M; Blandova G; Petrovic O; Janega P; Repiska V; Minarik G Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175518 [TBL] [Abstract][Full Text] [Related]
10. The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies. Czegle I; Huang C; Soria PG; Purkiss DW; Shields A; Wappler-Guzzetta EA Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109525 [TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. Bredin HK; Krakstad C; Hoivik EA PLoS One; 2023; 18(3):e0283203. PubMed ID: 36943861 [TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Zhou Z; Li P; Zhang X; Xu J; Xu J; Yu S; Wang D; Dong W; Cao X; Yan H; Sun M; Ding X; Xing J; Zhang P; Zhai L; Fan T; Tian S; Yang X; Hu M Mol Med; 2022 May; 28(1):55. PubMed ID: 35562651 [TBL] [Abstract][Full Text] [Related]
13. Emodin Promotes Apoptosis of Human Endometrial Cancer Through Regulating the MAPK and PI3K/ AKT Pathways. Jiang J; Zhou N; Ying P; Zhang T; Liang R; Jiang X Open Life Sci; 2018 Jan; 13():489-496. PubMed ID: 33817118 [TBL] [Abstract][Full Text] [Related]
14. Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer. Krishnamurthy S; Yoda H; Hiraoka K; Inoue T; Lin J; Shinozaki Y; Watanabe T; Koshikawa N; Takatori A; Nagase H Cancer Sci; 2021 Mar; 112(3):1141-1149. PubMed ID: 33377228 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive pharmacogenomic characterization of gastric cancer. Sa JK; Hong JY; Lee IK; Kim JS; Sim MH; Kim HJ; An JY; Sohn TS; Lee JH; Bae JM; Kim S; Kim KM; Kim ST; Park SH; Park JO; Lim HY; Kang WK; Her NG; Lee Y; Cho HJ; Shin YJ; Kim M; Koo H; Kim M; Seo YJ; Kim JY; Choi MG; Nam DH; Lee J Genome Med; 2020 Feb; 12(1):17. PubMed ID: 32070411 [TBL] [Abstract][Full Text] [Related]
16. PI3K expression predicts overall survival in lung adenocarcinoma. Li L; Liu D; Jin J; Zhu Y; Yang L; Song J; Li W; Huang Y Int J Clin Exp Pathol; 2018; 11(10):4889-4898. PubMed ID: 31949564 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019. Charo LM; Plaxe SC F1000Res; 2019; 8():. PubMed ID: 31231511 [TBL] [Abstract][Full Text] [Related]
18. Class I Phosphoinositide 3-Kinase Mazloumi Gavgani F; Smith Arnesen V; Jacobsen RG; Krakstad C; Hoivik EA; Lewis AE Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544563 [TBL] [Abstract][Full Text] [Related]